Microbiology & Infectious Diseases

Machine learning identifies key genes and potential treatments for sepsis, improving diagnosis and offering new therapeutic targets.

Findings revealed that microbiota maturation in cystic fibrosis is delayed, preventing the establishment of a stable, adult-like community.

New 9-month, all-oral regimens for fluoroquinolone-susceptible, rifampin-resistant tuberculosis are as effective as the standard longer-duration therapy.

The ECDC’s Annual Epidemiological Reports analysed surveillance data from 29 EU/EEA countries, tracking trends in gonorrhoea, syphilis, and chlamydia.

Researchers have identified key immunological markers associated with mortality in hospitalised people living with HIV/AIDS.

A new systematic review and network meta-analysis confirms that faecal microbiota transplantation is the most effective treatment for Clostridioides difficile infection.

Carbapenem-resistant Enterobacterales infections are on the rise across Europe, with experts warning of worsening transmission and increasing resistance.

Pseudomonas aeruginosa infection drives lung transplant rejection by inducing regulatory T cell death and promoting B cell responses.